We use cookies to enhance the usability of our website. If you continue, we'll assume that you are happy to receive all cookies. More information. Don't show this again.
On the top, protein expression in current human tissue, based on all annotated cell types, is reported with the units not detected (n), low (l), medium (m) and high (h). Underneath, protein expression in each annotated cell type are reported using the same units.
Protein expression data is based on knowledge-based annotation. For genes where more than one antibody has been used, a collective score is set.
If knowledge-based annotation could not be performed for a gene, no data is displayed here. View antibody staining data further down this page.
A summary of mRNA expression data available for current tissue based on several datasets. The mRNA expression levels in human tissues are based on RNA-seq data generated by the Human Protein Atlas (HPA), Genotype-Tissue Expression (GTEx) portal and CAGE data generated by the FANTOM5 consortium. Consensus normalized expression (NX) levels for human tissues was created by combining the data from these three transcriptomics datasets (HPA, GTEx and FANTOM5).
The mRNA expression levels in pig are based on RNA-seq data generated by the Human Protein Atlas (HPA), and for mouse, HPA data and in situ hybridization generated by the Allen brain atlas are reported.
Scroll down to view mRNA expression data in more detail.
Antibody staining in the annotated cell types in the current human tissue is reported as not detected, low, medium, or high. This score is based on the staining intensity and fraction of stained cells.
The RNA-seq details section shows detailed information about the individual samples used for the transcript profiling and results of the RNA-seq analysis.
Information about each individual sample is listed below, including gender, age, a tissue section image and estimated fractions of cell types. pTPM (transcripts per million) values give a quantification of the gene abundance which is comparable between different genes and samples.
Cells in tubules: 60 Cells in glomeruli: 20 Fibroblasts: 5 Other cell types: 15
Female, age 67
Kidney sample 56 pTPM: 36.5
Cell types%
Cells in tubules: 70 Cells in glomeruli: 15 Fibroblasts: 10 Other cell types: 5
Female, age 55
Kidney sample 57 pTPM: 53.4
Cell types%
Cells in tubules: 80 Cells in glomeruli: 10 Fibroblasts: 5 Other cell types: 5
Male, age 46
Kidney sample 58 pTPM: 54.9
Cell types%
Cells in tubules: 60 Cells in glomeruli: 25 Fibroblasts: 5 Other cell types: 10
Female, age 57
Kidney sample 358 pTPM: 2.1
Cell types%
Cells in tubules: 60 Cells in glomeruli: 10 Fibroblasts: 10 Other cell types: 20
Male, age 78
Kidney sample 377 pTPM: 6
Cell types%
Cells in tubules: 65 Cells in glomeruli: 10 Fibroblasts: 5 Other cell types: 20
Male, age 73
Kidney sample 380 pTPM: 3.4
Cell types%
Cells in tubules: 60 Cells in glomeruli: 10 Fibroblasts: 10 Other cell types: 20
Female, age 59
Kidney sample 394 pTPM: 9.8
Cell types%
Cells in tubules: 65 Cells in glomeruli: 10 Fibroblasts: 10 Other cell types: 15
Female, age 48
Kidney sample 414 pTPM: 2.4
Cell types%
Cells in tubules: 60 Cells in glomeruli: 5 Fibroblasts: 10 Other cell types: 25
KIDNEY - GTEx RNA-seqi
RNA-Seq data generated by the Genotype-Tissue Expression (GTEx) project from human tissues is reported as average pTPM. More information can be found on the GTEx portal.
Distribution across the dataset is visualized with box plots, shown as median and 25th and 75th percentiles. Points are displayed as outliers if they are above or below 1.5 times the interquartile range. pTPM values of the individual samples are presented next to the box plot.
Max pTPM: 320.5
Min pTPM: 14.1
Std pTPM: 73.0
Median pTPM: 45.1
GTEX-RN64-1626-SM-48FD7
50-59 years, male
320.5
GTEX-1399S-0526-SM-5IJG8
30-39 years, female
251.7
GTEX-ZLFU-0926-SM-5P9F8
40-49 years, male
229.2
GTEX-11TTK-1926-SM-5PNW8
60-69 years, female
226.1
GTEX-13OVI-1126-SM-5KLZF
60-69 years, female
216.6
GTEX-147F4-2626-SM-5Q5CS
50-59 years, male
188.8
GTEX-ZVZP-0926-SM-5GIDB
50-59 years, male
152.4
GTEX-1AX8Z-2326-SM-731CR
60-69 years, male
149.5
GTEX-ZE9C-1426-SM-4WKGM
60-69 years, male
125.7
GTEX-ZYFG-1626-SM-5GZYY
60-69 years, female
124.6
GTEX-145MN-0326-SM-5QGQI
30-39 years, male
113.6
GTEX-XPVG-0526-SM-4B65N
50-59 years, male
109.6
GTEX-1A3MW-2226-SM-73KUX
60-69 years, female
103.2
GTEX-17F97-1926-SM-7IGM4
50-59 years, male
86.8
GTEX-13112-2126-SM-5GCO4
50-59 years, male
84.5
GTEX-12696-0926-SM-5FQTV
60-69 years, male
81.3
GTEX-13OVL-1826-SM-5KLZR
50-59 years, male
76.6
GTEX-QLQW-1626-SM-4R1K1
30-39 years, male
74.5
GTEX-13RTJ-2226-SM-5S2Q1
60-69 years, male
71.3
GTEX-ZYT6-2226-SM-5GIC9
30-39 years, male
67.7
GTEX-1C6VQ-2326-SM-7IGN1
50-59 years, male
53.5
GTEX-15CHQ-2126-SM-6871M
60-69 years, male
47.9
GTEX-11GS4-2326-SM-5A5KS
60-69 years, male
45.1
GTEX-14C39-2126-SM-664OH
40-49 years, male
40.7
GTEX-1497J-0826-SM-5NQAJ
60-69 years, male
40.6
GTEX-QDVN-1626-SM-48TZC
50-59 years, male
40.6
GTEX-14E6D-2526-SM-5YYA9
50-59 years, male
39.7
GTEX-13NYB-1726-SM-5N9G2
40-49 years, male
34.6
GTEX-1EKGG-2226-SM-7IGOA
60-69 years, male
33.4
GTEX-ZC5H-1726-SM-5HL7X
40-49 years, female
33.3
GTEX-NPJ8-2226-SM-3TW8D
40-49 years, male
32.7
GTEX-1BAJH-1826-SM-731DA
70-79 years, male
32.5
GTEX-12WSG-0826-SM-5EQ5A
50-59 years, female
31.0
GTEX-P4QS-1126-SM-3NMD5
60-69 years, male
29.0
GTEX-T5JC-1526-SM-4DM68
20-29 years, male
28.2
GTEX-ZDXO-0226-SM-4WKH7
60-69 years, male
27.3
GTEX-N7MS-1626-SM-3LK5F
60-69 years, male
27.0
GTEX-13O1R-2526-SM-5N9FW
60-69 years, male
24.2
GTEX-11OF3-1326-SM-5N9FJ
60-69 years, male
23.9
GTEX-15DYW-2026-SM-6AJBD
60-69 years, female
23.6
GTEX-14C5O-2026-SM-5YYB1
60-69 years, male
21.1
GTEX-Y5V6-2026-SM-5IFHO
60-69 years, male
19.7
GTEX-16MT8-1926-SM-7EPGL
60-69 years, female
18.9
GTEX-17HHY-2326-SM-7KFSR
50-59 years, male
18.8
GTEX-13OW6-1826-SM-5N9F9
50-59 years, male
14.1
Show allShow less
KIDNEY - FANTOM5 CAGEi
RNA expression in human tissues obtained through Cap Analysis of Gene Expression (CAGE) generated by the FANTOM5 project are reported as Scaled Tags Per Million.